[1] | Yen BL, Huang HI, Chien CC, Jui HY, Ko BS, Yao M, Shun CT, Yen ML, Lee MC, Chen YC . Isolation of multipotent cells from human term placenta. Stem Cells, 2005,23(1):3-9. | [2] | Kern S, Eichler H, Stoeve J, Klüter H, Bieback K . Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells, 2006,24(5):1294-1301. | [3] | Yang XF, He X, He J, Zhang LH, Su XJ, Dong ZY, Xu YJ, Li Y, Li YL . High efficient isolation and systematic identification of human adipose-derived mesenchymal stem cells. J Biomed Sci, 2011,18(1):59. | [4] | Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH . Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood, 2004,103(5):1669-1675. | [5] | Romanov YA, Svintsitskaya VA, Smirnov VN . Searching for alternative sources of postnatal human mesenchymal stem cells: Candidate MSC-like cells from umbilical cord. Stem Cell, 2003,21(1):105-110. | [6] | Caplan AI . Mesenchymal stem cells. J Orthop Res, 1991,9(5):641-650. | [7] | Kuroda Y, Kitada M, Wakao S, Nishikawa K, Tanimura Y, Makinoshima H, Goda M, Akashi H, Inutsuka A, Niwa A, Shigemoto T, Nabeshima Y, Nakahata T, Nabeshima Y, Fujiyoshi Y, Dezawa M . Unique multipotent cells in adult human mesenchymal cell populations. Proc Natl Acad Sci USA, 2010,107(19):8639-8643. | [8] | Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringden O . HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol, 2003,31(10):890-896. | [9] | Klyushnenkova E, Mosca JD, Zernetkina V, Majumdar MK, Beggs KJ, Simonetti DW, Deans RJ , McIntosh KR.T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. J Biomed Sci, 2005,12(1):47-57. | [10] | Scheel C, Eaton EN, Li SH, Chaffer CL, Reinhardt F, Kah KJ, Bell G, Guo W, Rubin J, Richardson AL, Weinberg RA . Paracrine and autocrine signals induce and maintain mesenchymal and stem cell states in the breast. Cell, 2011,145(6):926-940. | [11] | Otto WR, Wright NA . Mesenchymal stem cells: from experiment to clinic. Fibrogenesis Tissue Repair, 2011,4(1):20. | [12] | Caplan AI, Correa D . The MSC: an injury drugstore. Cell Stem Cell, 2011,9(1):11-15. | [13] | Aggarwal S, Pittenger MF . Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood, 2005,105(4):1815-1822. | [14] | Ohno T, Kaneda H, Nagai Y, Fukushima M . Regenerative medicine in critical limb ischemia. J Atheroscler Thromb, 2012,19(10):883-889. | [15] | Zhao Y, Tang F, Xiao Z, Han G, Wang N, Yin N, Chen B, Jiang X, Yun C, Han W, Zhao C, Cheng S, Zhang S, Dai J . Clinical study of neuroregen scaffold combined with human mesenchymal stem cells for the repair of chronic complete spinal cord injury. Cell Transplant, 2017,26(5):891-900. | [16] | Trounson A , McDonald C.Stem cell therapies in clinical trials: Progress and challenges. Cell Stem Cell, 2015,17(1):11-22. | [17] | Mehta J, Mehta J, Frankfurt O, Altman J, Evens A, Tallman M, Gordon L, Williams S, Winter J, Krishnamurthy J, Duffey S, Singh V, Meagher R, Grinblatt D, Kaminer L, Singhal S . Optimizing the CD34 + cell dose for reduced-intensity allogeneic hematopoietic stem cell transplantation. Leuk Lymphoma, 2009,50(9):1434-1441. | [18] | Kehoe DE, Jing D, Lock LT, Tzanakakis ES . Scalable stirred-suspension bioreactor culture of human pluripotent stem cells. Tissue Eng Part A, 2010,16(2):405-421. | [19] | Duijvestein M, Vos AC, Roelofs H, Wildenberg ME, Wendrich BB, Verspaget HW, Kooy-Winkelaar EM, Koning F, Zwaginga JJ, Fidder HH, Verhaar AP , Fibbe WE,van den Brink GR, Hommes DW. Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study. Gut, 2010,59(12):1662-1669. | [20] | Serra M, Brito C, Correia C, Alves PM . Process engineeering of human pluripotent stem cells for clinical application. Trends Biotechnol, 2012,30(6):350-359. | [21] | Villa-Diaz LG, Ross AM, Lahann J, Krebsbach PH . Concise review: The evolution of human pluripotent stem cell culture: from feeder cells to synthetic coatings. Stem Cells, 2013,31(1):1-7. | [22] | Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj, Horwitz E . Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy, 2006,8(4):315-317. | [23] | Heathman TR, Stolzing A, Fabian C, Rafiq QA, Coopman K, Nienow AW, Kara B, Hewitt CJ . Scalability and process transfer of mesenchymal stromal cell production from monolayer to microcarrier culture using human platelet lysate. Cytotherapy, 2016,18(4):523-535. | [24] | Carmelo JG, Fernandes-Platzgummer A , Diogo MM,da Silva CL, Cabral JM. A xeno-free microcarrier-based stirred culture system for the scalable expansion of human mesenchymal stem/stromal cells isolated from bone marrow and adipose tissue. Biotechnol J, 2015,10(8):1235-1247. | [25] | Sun LY, Hsieh DK, Syu WS, Li YS, Chiu HT, Chiou TW . Cell proliferation of human bone marrow mesenchymal stem cells on biodegradable microcarriers enhances in vitro differentiation potential. Cell Prolif, 2010,43(5):445-456. | [26] | Petry F, Smith JR, Leber J, Salzig D, Czermak P, Weiss ML . Manufacturing of human umbilical cord mesenchymal stromal cells on microcarriers in a dynamic system for clinical use. Stem Cells Int, 2016,2016:4834616. | [27] | Santos F, Andrade PZ, Abecasis MM, Gimble JM, Chase LG, Campbell AM, Boucher S, Vemuri MC, Silva CL, Cabral JM . Toward a clinical-grade expansion of mesenchymal stem cells from human sources: a microcarrier- based culture system under xeno-free conditions. Tissue Eng Part C Methods, 2011,17(12):1201-1210. | [28] | Goh TK, Zhang ZY, Chen AK, Reuveny S, Choolani M, Chan JK, Oh SK . Microcarrier culture for efficient expansion and osteogenic differentiation of human fetal mesenchymal stem cells. Biores Open Access, 2013,2(2):84-97. | [29] | Kobolak J, Dinnyes A, Memic A, Khademhosseini A, Mobasheri A . Mesenchymal stem cells: Identification, phenotypic characterization, biological properties and potential for regenerative medicine through biomaterial micro-engineering of their niche. Methods, 2016,99:62-68. | [30] | Jossen V, van den Bos C, Eibl R, Eibl D . Manufacturing human mesenchymal stem cells at clinical scale: process and regulatory challenges. Appl Microbiol Biotechnol, 2018,102(9):3981-3994. | [31] | Yang Y, Rossi FM, Putnins EE . Ex vivo expansion of rat bone marrow mesenchymal stromal cells on microcarrier beads in spin culture. Biomaterials, 2007,28(20):3110-3120. | [32] | Eibes G, dos Santos F, Andrade PZ, Boura JS, Abecasis MM, da Silva CL, Cabral JM . Maximizing the ex vivo expansion of human mesenchymal stem cells using a microcarrier-based stirred culture system. J Biotechnol, 2010,146(4):194-197. | [33] | Schop D, van Dijkhuizen-Radersma R, Borgart E, Janssen FW, Rozemuller H, Prins HJ, de Bruijn JD . Expansion of human mesenchymal stromal cells on microcarriers: growth and metabolism. J Tissue Eng Regen Med, 2010,4(2):131-140. | [34] | Heathman TR, Glyn VA, Picken A, Rafiq QA, Coopman K, Nienow AW, Kara B, Hewitt CJ . Expansion, harvest and cryopreservation of human mesenchymal stem cells in a serum-free microcarrier process. Biotechnol Bioeng, 2015,112(8):1696-1707. | [35] | Rafiq QA, Brosnan KM, Coopman K, Nienow AW, Hewitt CJ . Culture of human mesenchymal stem cells on microcarriers in a 5 l stirred-tank bioreactor. Biotechnol Lett, 2013,35(8):1233-1245. | [36] | Wu QF, Wu CZ, Dong B, Wang LS . Cultivation of humanmesenchymal stem cells on macroporous CultiSpher G microcarriers.J Exp Hematol, 2003(1):15-21. | [36] | 吴清法, 吴祖泽, 董波, 王立生 . 微载体悬浮培养成人骨髓间充质干细胞. 中国实验血液学杂志, 2003(1):15-21. | [37] | Han BS, Shen BY, Peng CH, Shi MM, Cheng DF, Wang XM, Wang ZH, Zhou GW, Li HW . Scale-up culture of adult human mesenchymal stem cells on microcarrier Cytodex 3.J Shanghai Jiao Tong Univ Med Sci, 2006(6):581-585. | [37] | 韩宝三, 沈柏用, 彭承宏, 施敏敏, 程东峰, 王小明, 王兆海, 周光文, 李宏为 , 微载体cytodex 3大量扩增成人骨髓间充质干细胞的初步研究. 上海交通大学学报(医学版), 2006(6):581-585. |
|